Now, with full-year revenue of about nearly $230 million, Provenge and Dendreon have been vindicated to some degree. ???There???s a lot of exuberance today,??? Joseph Pantginis, an analyst for Roth Capital Partners in New York, told Bloomberg in a telephone interview. ???The most important thing is that people are gathering some comfort because they look like they???re on the right track with rega